DROSHA and cancer: Considering the abundance of CDK inhibitors and the characteristics of TBI, we identified the time frame during which stabilizing Drosha levels with two promising CDK inhibitors, which have entered clinical trials for cancer treatment, is effective for the early treatment of TBI.